Clinical Trials Directory

Trials / Conditions / Cerebral Cavernous Malformation

Cerebral Cavernous Malformation

8 registered clinical trials studyying Cerebral Cavernous Malformation.

StatusTrialSponsorPhase
TerminatedFunctional Magnetic Resonance Imaging (fMRI) Vascular Reactivity in Cerebral Cavernous Malformations (CCM)
NCT05298709
University of New MexicoN/A
CompletedThe Symptomatic Cerebral Cavernous Malformation Trial of REC-994
NCT05085561
Recursion Pharmaceuticals Inc.Phase 2
TerminatedCCM Blood Biomarker Validation Study
NCT05148663
Texas Tech University Health Sciences Center, El Paso—
Active Not RecruitingBiomarkers of CASH
NCT04467489
University of Chicago—
CompletedCASH (Cavernous Angiomas With Symptomatic Hemorrhage) Trial Readiness
NCT03652181
University of Chicago—
CompletedAtorvastatin Treatment of Cavernous Angiomas With Symptomatic Hemorrhage Exploratory Proof of Concept (AT CASH
NCT02603328
University of ChicagoPhase 1 / Phase 2
CompletedTreat_CCM: Propranolol in Familial Cerebral Cavernous Malformation
NCT03589014
Mario Negri Institute for Pharmacological ResearchPhase 2
UnknownCoHOrt of Cerebral CavernOus maLformATion: multicEnter Prospective Observational Study
NCT02946866
Seoul National University Hospital—